OSCR

Selective non-nuclear estrogen receptor activation with PaPE-1 evokes neuroprotection involving mTOR/MEK in an in vitro model of hypoxic/ischemic injury.

Overview

  1. Maj Institute of Pharmacology, Polish Academy of Sciences, Department of Pharmacokinetics and Drug Metabolism, Team III, Smętna12, Kraków, 31-343 Poland
  2. Maj Institute of Pharmacology, Polish Academy of Sciences, Department of Experimental Neuroendocrinology, Laboratory of Immunoendocrinology, Smętna 12, Kraków, 31-343 Poland
Journal: Pharmacological reports : PR, volume 78, issue 4, pages 1145-1178
Dates: received 26 January 2026; accepted 7 May 2026; published online 28 May 2026; in print 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1007/s43440-026-00866-2 · PMID 42207471 · PMCID PMC13437761 · OpenAlex W7162697673
Open access: hybrid, a free copy (OpenAlex)
Categories: mouse (organism), stroke (population), cellular / molecular (subfield)
Methods: Statistics, fMRI & imaging
Keywords: Ischemic stroke, Non-nuclear estrogen receptors signaling, Neurodegeneration, Autophagy, MiRNA
MeSH: Hypoxia-Ischemia, Brain*, Neuroprotective Agents*, Receptors, Estrogen*, TOR Serine-Threonine Kinases*, Animals, Autophagy, Cell Survival, Cells, Cultured, Indans, Mice, Neurons, Neuroprotection, Signal Transduction (* major topic)
Topic: Menopause: Health Impacts and Treatments (Endocrinology, Diabetes and Metabolism, Medicine), according to OpenAlex
Citations: not cited yet (Europe PMC); 73 references in the paper

Abstract

Background: Hypoxic/ischemic brain injuries, including ischemic stroke and perinatal asphyxia, remain major causes of mortality and long-term neurological disability, establishing a demand for therapeutic strategies suitable against the multifactorial nature of underlying mechanisms. Estrogen receptors (ERs) signaling is known to exert neuroprotective effects, however, genomic ER activation is associated with serious adverse effects, including carcinogenesis and thromboembolisms. Pathway Preferential Estrogen-1 (PaPE-1), a compound that selectively activates the non-nuclear subset of ERs, may provide neuroprotection, thereby overcoming the deleterious effects. The aim of this study was to elucidate the molecular mechanisms underlying the neuroprotective effects of PaPE-1 in an in vitro model of hypoxic-ischemic neuronal injury, with particular emphasis on non-nuclear estrogen receptor signaling and its downstream pathways.

Methods: Primary mouse cortical neuronal cells were subjected to 6 hours of experimental hypoxic/ischemic injury, followed by 18 hours of post-treatment with PaPE-1. Subsequently, a variety of biochemical assessments were conducted, including measurements of neuronal viability, cell death, and formation of autophagy-related vesicles. Moreover, the influence of PaPE-1 was assessed with molecular methods, encompassing measurements of gene and protein expression level and a set of epigenetic-related parameters, for instance, assessment of global DNA/RNA methylation and locus-specific methylation of genes and miRNA expression. To dissect signaling pathways, selective pharmacological inhibitors targeting mTOR/MEK1/2 and autophagy regulators were applied. ER subtype involvement was examined using ER-selective antagonists and specific siRNA silencing.

Results: Non-nuclear ER activation with PaPE-1 attenuated maladaptive autophagy, RNA/DNA oxidative stress damage, and neuronal degeneration while contributing to the regulation of gene expression and epigenetic processes. Evocation of robust neuroprotection involved modulation of mTOR and MEK1/2 signaling, predominantly mediated by estrogen receptor 1 (ESR1).

Conclusion: In conclusion, PaPE-1 exhibits a multitarget mode of action that provides broad-spectrum protection against hypoxic/ischemic neuronal injuries. Considering its complexity of action and confirmed strong, neuroprotective activity, this compound holds promise for broader evaluation across different brain cell types and in vivo models.

Supplementary Information: The online version contains supplementary material available at 10.1007/s43440-026-00866-2.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability

The datasets generated and/or analyzed during the current study are available in the Zenodo repository - 10.5281/zenodo.19706750.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Publisher: n/a → Elsevier BV
  • Funding: added European Commission; Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 4 authors, 5 keywords, 13 MeSH terms, 73 references.

Cite

This paper

Łach, A., Pietrzak-Wawrzyńska, B. A., Przepiórska-Drońska, K., & Wnuk, A. (2026). Selective non-nuclear estrogen receptor activation with PaPE-1 evokes neuroprotection involving mTOR/MEK in an in vitro model of hypoxic/ischemic injury. Pharmacological reports : PR, 78(4), 1145-1178. https://doi.org/10.1007/s43440-026-00866-2

BibTeX

@article{ach2026selective,
author = {Łach, Andrzej and Pietrzak-Wawrzyńska, Bernadeta A and Przepiórska-Drońska, Karolina and Wnuk, Agnieszka},
title = {{Selective non-nuclear estrogen receptor activation with PaPE-1 evokes neuroprotection involving mTOR/MEK in an in vitro model of hypoxic/ischemic injury}},
journal = {Pharmacological reports : PR},
year = {2026},
month = may,
volume = {78},
number = {4},
pages = {1145--1178},
publisher = {Elsevier BV},
issn = {1734-1140},
doi = {10.1007/s43440-026-00866-2},
url = {https://doi.org/10.1007/s43440-026-00866-2},
pmid = {42207471},
pmcid = {PMC13437761}
}

RIS

TY - JOUR
AU - Łach, Andrzej
AU - Pietrzak-Wawrzyńska, Bernadeta A
AU - Przepiórska-Drońska, Karolina
AU - Wnuk, Agnieszka
TI - Selective non-nuclear estrogen receptor activation with PaPE-1 evokes neuroprotection involving mTOR/MEK in an in vitro model of hypoxic/ischemic injury
T2 - Pharmacological reports : PR
J2 - Pharmacol Rep
PY - 2026
DA - 2026/05/28
VL - 78
IS - 4
SP - 1145
EP - 1178
SN - 1734-1140
PB - Elsevier BV
DO - 10.1007/s43440-026-00866-2
UR - https://doi.org/10.1007/s43440-026-00866-2
LA - en
ER -

CSL-JSON

{
"id": "10.1007/s43440-026-00866-2",
"type": "article-journal",
"title": "Selective non-nuclear estrogen receptor activation with PaPE-1 evokes neuroprotection involving mTOR/MEK in an in vitro model of hypoxic/ischemic injury",
"container-title": "Pharmacological reports : PR",
"author": [
{
"family": "Łach",
"given": "Andrzej"
},
{
"family": "Pietrzak-Wawrzyńska",
"given": "Bernadeta A"
},
{
"family": "Przepiórska-Drońska",
"given": "Karolina"
},
{
"family": "Wnuk",
"given": "Agnieszka"
}
],
"container-title-short": "Pharmacol Rep",
"volume": "78",
"issue": "4",
"page": "1145-1178",
"DOI": "10.1007/s43440-026-00866-2",
"PMID": "42207471",
"PMCID": "PMC13437761",
"ISSN": "1734-1140",
"publisher": "Elsevier BV",
"URL": "https://doi.org/10.1007/s43440-026-00866-2",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
28
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3389/fmolb.2026.1844734
Discovery and validation of programmed cell death-associated key biomarker genes in ischemic stroke via ssGSEA/WGCNA and LASSO-SVM-RFE.
Journal: Frontiers in molecular biosciences
In common: stroke, 3 references
[2] doi:10.1007/s10565-026-10177-0
Multi-omics analysis and experimental validation reveal the IRF7-CXCL10 axis as a master regulator of microglial PCD in ischemic stroke.
Journal: Cell biology and toxicology
In common: stroke, mouse, cellular / molecular, 2 references
[3] doi:10.1002/jev2.70295
RVG-Modified BMSCs-Derived Small Extracellular Vesicles Loaded With miR-21 Alleviate Neuronal Injury Resulted From Excessive Autophagy via Targeting PTEN/Akt/mTOR Pathway After Cerebral Ischaemia.
Journal: Journal of extracellular vesicles
In common: stroke, mouse, cellular / molecular, 2 references
[4] doi:10.1186/s13062-026-00912-2
Integrated analysis of single-cell transcriptome identifies a glial-neurovascular signaling trajectory in brain repair after ischemia.
Journal: Biology direct
In common: stroke, mouse, cellular / molecular, 2 references
[5] doi:10.1186/s12915-025-02301-z
Targeting the complement-mTOR-autophagy axis: the role of apolipoprotein E in depression.
Journal: BMC biology
In common: mouse, cellular / molecular, 2 references
[6] doi:10.1186/s12964-024-01872-8
USP9X-mediated deubiquitination of Raptor contributes to autophagy impairment and memory deficits in P301S mice.
Journal: Cell communication and signaling : CCS
In common: mouse, cellular / molecular, 2 references
[7] doi:10.18632/aging.203883
MRTF-A-mediated protection against amyloid-β-induced neuronal injury correlates with restoring autophagy via miR-1273g-3p/mTOR axis in Alzheimer models.
Journal: Aging
In common: mouse, cellular / molecular, 2 references
[8] doi:10.1111/cns.70399
S-Propargyl-Cysteine Attenuates Stroke Heterogeneity via Promoting Protective Autophagy Across Multiple Neural Cell Types: Insights From Single-Cell Sequencing.
Journal: CNS neuroscience & therapeutics
In common: stroke, mouse, cellular / molecular, 1 reference
[9] doi:10.1186/s12974-022-02676-8
Inhibition of CCR2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the PI3K/Akt pathway.
Journal: Journal of neuroinflammation
In common: stroke, mouse, cellular / molecular, 1 reference
[10] doi:10.1016/j.jbc.2022.101721
Inactivation of mouse transmembrane prolyl 4-hydroxylase increases blood brain barrier permeability and ischemia-induced cerebral neuroinflammation.
Journal: The Journal of biological chemistry
In common: stroke, mouse, cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.